U.S. Human Microbiome Market is expected to reach USD 1,528.06 million by 2029

Microbiota means the microbial taxa associated with humans and microbiome means "the catalog of these microbes and their genes. The aggregation of all the microbiota reside on or within human tissues and bio fluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract and others. The human microbiota consists of the 10-100 trillion symbiotic microbial cells harbored by each person, primarily bacteria in the gut. The human microbiome consists of the genes these cells harbor.

U.S. human microbiome market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyzes that the market is growing with a CAGR of 23.9% in the forecast period of 2022 to 2029 and is expected to reach USD 1,528.06 million by 2029.

Read more:
https://www.databridgemarketresearch.com/reports/us-human-microbiome-market

Market Definition

Microbiome is the genetic material of all the microbes - bacteria, fungi, protozoa and viruses - that live on and inside the human body. The number of genes in all the microbes in one person's microbiome is 200 times the number of genes in the human genome. The most widely used method of identification of microbiome analysis is 16s rRNA sequencing. Identification and understanding of these microbiotas have led to the application of these microorganisms in the betterment of human health via various products such as probiotics, prebiotics and other associated drugs.

U.S. Human Microbiome Market Dynamics
Drivers

Rising prevalence of lifestyle and chronic diseases

Due to global rise of chronic diseases, there is an increase in the demand for effective treatment products which will increase in upcoming years. Therefore, rising incidences are expected to act as a driver for the growth of the market.

Increasing technological advancements in metagenomics and next-generation sequencing

Metagenomics is a novel methodology for studying microorganisms obtained from specific environments through functional gene screening. It is focused on microbial diversity, genetic relationships, functional activities and relationships with the environment, whereas sequencing technology is used for the diagnosis or the treatment of disease evolved from shot-gun sequencing, high-throughput, next-generation sequencing and third-generation sequencing. Next generation and third generation sequencing shows the advantage of rapid detection of microorganisms.

Furthermore, improved technology advancement, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will drive the growth of the market.

GET A PDF SAMPLE:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=us-human-microbiome-market

Competitive Landscape and Human Microbiome Market Share Analysis
The U.S. human microbiome market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth and application dominance. The above data points provided are only related to the companies' focus on the market.

Some of the major players operating in the U.S. market are 4D pharma plc, Evelo Biosciences, Inc., Viome Life Sciences, Inc., Finch Therapeutics Group, Inc., OptiBiotix HEALTH PLC, BiomX, Sun Genomics, Metabiomics, Osel Inc., Ferring B.V., Merck KGaA, Assembly Biosciences, Inc., Synthetic Biologics, Inc., FlightPath Biosciences, Inc., Vedanta Biosciences, Inc. and Second Genome among others.

More links:

https://dbmrbuisness.blogspot.com/2023/08/asia-pacific-neuroendocrine-tumors.html

https://dbmrbuisness.blogspot.com/2023/08/middle-east-and-africa-neuroendocrine.html

https://dbmrbuisness.blogspot.com/2023/08/north-america-neuroendocrine-tumors.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.